1. Introduction and rationale
=============================

Obesity is a major concern all over the world affecting mainly adult and adolescent population.^\[[@R1]\]^ It is associated with a high incidence of many preventable co-morbidities including diabetes, cardiovascular disease, and cancer.^\[[@R2]\]^ For most patients, bariatric surgery remains the only option for the treatment of obesity when dietary interventions and medications fail. Currently used bariatric surgery \[laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB)\] lead to various degree of weight loss.^\[[@R3]\]^ However, there has been a rising incidence in complications associated with these procedures. Gastroesophageal reflex disease (GERD) in particular has been the subject of such concerns.^\[[@R4]\]^ The prevalence of clinically relevant GERD associated with bariatric surgery is variable but has been reported as ranging between 7% and 14%.^\[[@R5]--[@R7]\]^ Uncertainty however remains regarding the exact prevalence as well as the case burden especially among patients with different clinical phenotypes such as metabolic syndrome and obesity multi-morbidities. Factors accounting for this apparent lack of agreement on the data includes differences in background characteristics of patient populations as well as the clinical phenotypes of the patient population studied. In this synthesis, we intend to carry out a systematic review and meta-analysis of current evidence with the view to clarify the exact burden of GERD among patients that have undergone bariatric surgery.

2. Objective
============

The key objective of this study is to carry out a systematic review with meta analysis of controlled trials with the view to evaluate and clarify the exact burden of GERD following main modalities of bariatric surgery procedures (LSG and LRYGB).

3. Overview
===========

This study will be conducted in line with the recommendation of Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines^\[[@R8]\]^ for meta-analyses of healthcare interventions. Additionally, the current protocol outline adheres strictly to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P).^\[[@R9]\]^ This protocol is registered in International Prospective Register of Systematic Reviews (registration number: CRD42018090074).

4. Methodology
==============

4.1. Population
---------------

This review study population will comprise of studies reporting on frequency of GERD following bariatric surgery (LSG and LRYGB).

4.2. Intervention
-----------------

Bariatric surgery (LSG and LRYGB).

### 4.2.1. Study outcomes

Development of newly onset, worsened, or improved GERD among this population.

4.3. Study eligibility criteria
-------------------------------

### 4.3.1. Inclusion criteria

In this review, we will include studies that meet the following inclusion criteria:

1.  Age \> 18 years.

2.  History of bariatric surgery.

3.  All indications for bariatric surgery.

4.  Studies reporting on outcomes that includes GERD and its prevalence.

5.  Studies published in English language published from January 1, 2005 to January 31, 2019.

4.4. Exclusion criteria
-----------------------

All other studies that fail to satisfy the afore-mentioned inclusion criteria.

4.5. Literature sources
-----------------------

Relevant studies for this review will be sources from the following publicly available databases

-   Controlled clinical trials

-   Cochrane Controlled Trials Register (CCTR)

-   Cochrane Database of Systematic Reviews (CDSR)

-   EMBASE

-   Database of Abstracts of Reviews of Effectiveness (DARE)

-   MEDLINE

-   Science Citation Index (SCI)

-   Index to Scientific and Technical Proceedings (ISTP)

-   National Research Register (NRR)

4.6. Search strategy
--------------------

This study\'s search strategy will aim to identify published controlled clinical trials between January 1, 2005 and January 1, 2019 using the following medical search operators gastroesophageal reflux\[tiab\] OR bariatric surgery\[tiab\] OR laparoscopic sleeve gastrectomy\[tiab\] OR laparoscopic Roux-en-Y gastric bypass\[tiab\] AND (Clinical Trial\[ptyp\] AND "humans"\[MeSH Terms\]) from the following sources:

-   Controlled clinical trials

-   Cochrane Controlled Trials Register (CCTR)

-   Cochrane Database of Systematic Reviews (CDSR)

-   EMBASE

-   Database of Abstracts of Reviews of Effectiveness (DARE)

-   MEDLINE

-   Science Citation Index (SCI)

-   Index to Scientific and Technical Proceedings (ISTP)

-   National Research Register (NRR)

4.7. Criteria for study selection
---------------------------------

All studies that met eligibility criteria will be abstracted from publicly available electronic databases and imported in study specific database. Duplicates will be removed. Two reviewers will each independently assess full text of for inclusion in the review.

5. Interventions
================

Studies included this review will be those that report on patients that have undergone bariatric surgery (LSG and LRYGB) for a wide variety of reasons and reported on the prevalence of GERD in those populations.

5.1. Data collection/abstraction
--------------------------------

Data will be collected in a study specific case record form which was initially trialed on a randomly selected study. This data will then be transferred to a Microsoft specific database by the first author\'s last name and the year of publication.

5.2. Study bias risk assessment
-------------------------------

We will carry out risk of bias assessment of the all included studies and ascertain the magnitude of their bias disposition on the review outcome estimate.

5.3. Data analyses/synthesis
----------------------------

### 5.3.1. Estimation/calculation of effect sizes

We will determine the pooled estimates of our review outcome from effect sizes \[relative risk (RR), odds ratio (OR), and count data\] of the constituent studies by random effect models. We will generate other models (fixed effects and inverse heterogeneity models) for comparison.

Secondary outcomes will be calculated using the same procedure as for primary outcome.

5.4. Analytical software for data synthesis
-------------------------------------------

All statistical analysis will be carried out with MetaXL software (version 5.3 © EpiGear International Pty Ltd ABN 51,134,897,411 Sunrise Beach, Queensland, Australia, 2011--2016).

6. Statistical analysis
=======================

6.1. Strategy for dealing with missing data
-------------------------------------------

In the event of missing data from any of the reviews outcome of interest, we will request this from the corresponding authors of the studies concerned.

6.2. Sensitivity analysis
-------------------------

We will carry out sensitivity analysis where necessary to ascertain the exact effect of individual studies on the overall review outcome.

6.3. Ascertainment of heterogeneity
-----------------------------------

We will determine heterogeneity by estimating and comparing Cochran Q and *I*^2^ statistics.

7. Discussion
=============

We anticipate the outcome of this review will provide clarity regarding the exact phenotype and burden of GERD following bariatric surgery. This is of utmost importance both for clinical commissioning of measures to address this but also for laying foundation for further studies.
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